ChemicalBook > Product Catalog >API >Antibiotics >Aminoglycosides drugs >FORTIMICIN

FORTIMICIN

FORTIMICIN Structure
CAS No.
55779-06-1
Chemical Name:
FORTIMICIN
Synonyms
kw-1070;XK-70-1;Astricin;astromicin;FORTIMYCIN;FORTIMICIN;ASTROMYCIN;fortimicina;Fortimycin A;antibiotickw-1070
CBNumber:
CB7116881
Molecular Formula:
C17H35N5O6
Molecular Weight:
405.49
MOL File:
55779-06-1.mol
MSDS File:
SDS
Modify Date:
2022/12/21 16:56:50

FORTIMICIN Properties

Melting point >200° (dec)
alpha D25 +87.5° (c = 0.1 in water)
Boiling point 526.82°C (rough estimate)
Density 1.0897 (rough estimate)
refractive index 1.7600 (estimate)
pka 13.16±0.70(Predicted)

SAFETY

Risk and Safety Statements

Toxicity LD50 (of the sulfate salt) in mice (mg/kg): 380 i.v.; 400 s.c. (Nara, 1977)

FORTIMICIN Chemical Properties,Uses,Production

Definition

ChEBI: An amino cyclitol glycoside that is L-chiro-inositol in which the hydroxy groups at positions 1, 4, and 6 are replaced by aminoacetyl)methylamino, amino, and methoxy groups, respectively, and in which the hydroxy group at posi ion 3 is converted to the corresponding 2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranoside. The major component of fortimicin, obtained from Micromonospora olivasterospora. It is adm nistered (as the sulfate salt) by intramuscular injection or intravenous infusion for the treatment of severe systemic infections due to sensitive Gram-negative organisms.

Antimicrobial activity

A pseudodisaccharide aminoglycoside produced by Micromonospora olivoasterospora. Formulated as the sulfate. Intrinsic activity is similar to that of amikacin for most groups of organisms, but activity against Ps. aeruginosa is relatively poor. It is resistant to many aminoglycoside-modifying enzymes, but is sensitive to AAC(3) and the APH(2″)/AAC(6′) bifunctional enzyme.
Peak concentrations of 10–12 mg/L were found in the blood following 200 mg intravenous or intramuscular administration to volunteers. The plasma half-life was 1.5–2 h. Over 85% of the drug was recovered in urine during the 8 h following administration.
Toxicity and side effects are similar to those observed with other aminoglycosides. Where the drug is available it is used instead of amikacin in the treatment of infections caused by susceptible organisms.

Global( 24)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Shaanxi Dideu Medichem Co. Ltd +86-029-89586680 +86-18192503167 China 9030 58 Inquiry
Hangzhou MolCore BioPharmatech Co.,Ltd. +86-057181025280; +8617767106207 China 49739 58 Inquiry
TargetMol Chemicals Inc. +1-781-999-5354 United States 19973 58 Inquiry
Shaanxi Cuikang Pharmaceutical Technology Co., Ltd +86-19164747840 +86-13119157289 China 2969 58 Inquiry
BOC Sciences 1-631-485-4226; 16314854226 United States 14059 65 Inquiry
Zhejiang Huida Biotech Co., LTD 0571-0571-89903882 15990081639 China 3705 58 Inquiry
Amatek Scientific Co. Ltd. 0512-56316828 China 28819 58 Inquiry
Zhejiang Huida Biotech Co., LTD 0571-89903882 13626641628 China 3656 58 Inquiry
Sequoia Research Products Ltd. 44 7802 291086 United Kingdom 3115 69 Inquiry
AK Scientific, Inc. 650 494 8666 United States 6357 65 Inquiry
4,6,7-pentadeoxy-beta-l-lyxo-heptopyranosyl)-6-o-methyl-mino-3 antibiotickw-1070 4-Amino-1-[(aminoacetyl)methylamino]-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-6-O-methyl-L-chiro-inositol XK-70-1 ASTROMICIN SULPHATE FORTIMICIN FORTIMYCIN Abbott-44747:XK-70-1 astromicin fortimicina kw-1070 l-chiro-inositol,4-amino-1-((aminoacetyl)methylamino)-1,4-dideoxy-3-o-(2,6-dia L-chiro-Inositol, 4-amino-1-[(aminoacetyl)methylamino]-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-6-O-methyl- Fortimycin A 4-Amino-1-(2-amino-N-methylacetamido)-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-6-O-methyl-L-ehiroinositol ASTROMYCIN L-chiro-Inositol, 4-amino-1-[(2-aminoacetyl)methylamino]-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-6-O-methyl- FORTIMICIN USP/EP/BP Astricin 55779-06-1 C17H35N5O6